Diseases, Conditions, Syndromes

Infection risk does not seem to differ among biologics for psoriasis

(HealthDay)—Among biologics used for the treatment of psoriasis, there do not appear to be differential risks for serious infection or respiratory tract infection, according to a study presented at the annual meeting of ...

Medical research

Glycerin is safe, effective in psoriasis model

Patients with psoriasis have reported that glycerin, an inexpensive, harmless, slightly sweet liquid high on the list of ingredients in many skin lotions, is effective at combatting their psoriasis and now scientists have ...

Inflammatory disorders

Patient-reported outcome measures may aid psoriasis treatment

(HealthDay)—The use of patient-reported outcome measures (PROMs) to complement clinician-reported outcomes (CROs) may yield important information for assessing disease severity and guiding treatment of psoriasis, according ...

Inflammatory disorders

Factors linked to development of pediatric psoriasis identified

(HealthDay)—Atopic dermatitis, a family history of psoriasis, and skin viral and bacterial infection and fungal infections in early life are associated with pediatric psoriasis development, according to a study published ...

Oncology & Cancer

Risk of psoriasis increased for cancer survivors

(HealthDay)—Cancer survivors, especially survivors of hematologic malignancies, have an increased risk for psoriasis, according to a research letter published online June 30 in the British Journal of Dermatology.

Immunology

Questionnaire responses about dermatology history inconsistent

(HealthDay)—Asking people about a history of psoriasis may be useful for assessing psoriasis prevalence, but a similar questionnaire assessing atopic dermatitis does not appear to be as reliable of a method, according to ...

page 10 from 38